M. Ageta

发表

A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance

J. Sasaki, S. Kono, Y. Ikeda, 2008, Clinical therapeutics.

Efficacy and safety of a new HMG-CoA reductase inhibitor, NK-104, in patients with hypertriglyceridemia — Randomized double-blind, cross-over placebo controlled study

J. Sasaki, K. Arakawa, Y. Ikeda, 2000 .

Regional cerebral blood flow in diabetic patients: evaluation by N‐isopropyl-123I‐IMP with SPECT

H. Hoshi, S. Jinnouchi, S. Futami, 1994, Nuclear medicine communications.

A Comparative Study of Olmesartan and Valsartan on Insulin Sensitivity in Hypertensive Patients with Diabetes Mellitus or Impaired Glucose Tolerance (OVIS Study)

J. Sasaki, S. Kono, S. Biro, 2014 .

MECHANISM OF THE APPEARANCE OF β-K BAND IN THE FRACTION OF LIPOPROTEIN BY POLYACRYLAMIDE GEL-DISC ELECTROPHORESIS AND THE FREQUENCY OF ITS APPEARANCE IN IHD

M. Ageta, S. Yamasaki, S. Nanbu, 1975 .

Effects of fenofibrate on high-density lipoprotein particle size in patients with hyperlipidemia: a randomized, double-blind, placebo-controlled, multicenter, crossover study.

J. Sasaki, Kyosuke Yamamoto, M. Ageta, 2002, Clinical therapeutics.

A long-term comparative trial of cerivastatin sodium, a new HMG-CoA reductase inhibitor, in patients with primary hypercholesterolemia.

J. Sasaki, S. Kono, K. Arakawa, 1998, Clinical therapeutics.

Serum lipoprotein(a) concentration and Apo(a) isoform under the condition of renal dysfunction.

M. Ageta, I. Ikushima, M. Kuboyama, 2003, Journal of atherosclerosis and thrombosis.

A novel mutant, ApoA-I nichinan (Glu235-->0), is associated with low HDL cholesterol levels and decreased cholesterol efflux from cells.

J. Sasaki, K. Arakawa, S. Horiuchi, 1999, Arteriosclerosis, thrombosis, and vascular biology.

EFFECTS OF DIETARY PROTEIN CONTENTS ON THE CARDIAC CONTRACTILITY AND THE MYOCARDIAL STRUCTURE IN THE SPONTANEOUSLY HYPERTENSIVE RAT

M. Ageta, 1978 .

GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

Roger A. Nadeau, Jonathan B Sumner, T. Furukawa, 2022, Clinical Research in Cardiology.

Biosynthesis of lipoproteins in intestine with special reference to the effect of administration of lipids on lymphatic chylomicron

M. Ageta, K. Kosuga, S. Nanbu, 1975 .

Tuberculous liver abscess treated by percutaneous infusion of antituberculous agents.

T. Yamanaka, S. Nagamachi, M. Ageta, 1994, Internal medicine.

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

Mehrad Amin Eskandari, J. F. Tinto, A. Capucci, 2018, Indian heart journal.

Novel mutations in ABCA1 gene in Japanese patients with Tangier disease and familial high density lipoprotein deficiency with coronary heart disease.

J. Sasaki, T. Teramoto, M. Ageta, 2001, Biochimica et biophysica acta.

Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data

Pedro F. Campos, Roger A. Nadeau, Jonathan B Sumner, 2021, BMJ.

GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

Roger A. Nadeau, Jonathan B Sumner, T. Furukawa, 2022, Clinical Research in Cardiology.